CvN); 1H NMR (400 MHz, DMSO-d6) δH 11.77 (4H, brs,
NH), 8.35 (1H, brs, CHvN), 7.95–7.87 (2H, m, CHvN),
7.74–7.11 (9H, m, CHvN and ArH), 5.38 (2H, brs, CH),
5.20–4.99 (4H, m, CH2), 4.76 (1H, brs, CH), 4.49 (1H, brs,
CH); 13C NMR (100 MHz, DMSO-d6) δC 170.5, 165.7, 148.9,
144.4, 134.3, 128.0, 97.5, 77.3; MS (ESI-MS, DMF and ACN,
HCTultra) m/z (Calcd 576.2; exp. 577.1, M + H+, 100%),
(HRMS, APCI-TOF, DMSO) m/z (Calcd 577.1790; meas.
577.1782, M + H+).
CvN); 1H NMR (400 MHz, DMSO-d6) δH 11.72 (4H, brs,
NH), 8.39 (1H, brs, CHvN), 7.94 (2H, brs, CHvN), 7.79–7.04
(17H, m, CHvN and ArH), 5.38 (2H, brs, CH), 5.19–5.02 (4H,
m, CH2), 4.75–4.32 (2H, m, CH); MS (APCI-MS2, DMSO,
HCTultra) m/z (Calcd 728.2; exp. 729.2, M + H+, 100%), (Calcd
728.2; exp. 727.2, M − H+, 100%).
(3R,4R,22R,23R)-Tetra-carbohydrazide cyclophane (13)
Prepared from (4R,5R)-1,3-dioxolane-4,5-dicarbohydrazide (2)
and 4-(4-formylphenoxy)benzaldehyde as a white solid precipi-
tate (99%); mp > 315 °C (decomp.); IR νmax/cm−1 3220 (NH),
(3R,4R,21R,22R)-Tetra-carbohydrazide cyclophane (9)
1
Prepared from (4R,5R)-1,3-dioxolane-4,5-dicarbohydrazide (2)
and 4,4′-diformylbiphenyl as a yellow solid precipitate (98%);
mp > 340 °C (decomp.); IR νmax/cm−1 3211 (NH), 1672 (CvO,
CvN); 1H NMR (400 MHz, DMSO-d6) δH 11.72 (4H, brs,
NH), 7.94 (2H, brs, CHvN), 7.79–7.05 (18H, m, CHvN and
ArH), 5.38–5.02 (6H, m, CH and CH2), 4.48 (1H, brs, CH),
4.33 (1H, brs, CH); MS (ESI-MS, DMSO, HCTultra) m/z (Calcd
728.2; exp. 729.2, M + H+, APCI-MS2, 100%), (HRMS,
APCI-TOF, DMSO) m/z (Calcd 729.2475; meas. 729.2508,
M + H+).
1681 (CvO, CvN); H NMR (400 MHz, DMSO-d6) δH 11.66
(4H, brs, NH), 8.34 (1H, brs, CHvN), 8.06 (1H, brs, CHvN),
7.93 (1H, brs, CHvN), 7.71–7.43 (9H, m, CHvN and ArH),
7.09–6.65 (8H, m, ArH), 5.42 (2H, brs, CH), 5.42–5.10 (4H,
1
brs, CH2), 4.75 (1H, brs, CH), 4.54 (1H, brs, CH); H NMR
(400 MHz, DMF-d7) δH 11.70 (2H, brs, NH), 11.54 (2H, brs,
NH), 8.51 (1H, brs, CHvN), 8.28 (1H, brs, CHvN), 8.12 (1H,
brs, CHvN), 8.00–7.94 (1H, m, CHvN), 7.76 (7H, m, ArH),
7.57 (1H, brs, ArH), 7.14–6.83 (8H, m, ArH), 5.65 (1H, brs,
CH), 5.59 (1H, brs, CH), 5.35–5.23 (4H, m, CH2), 4.90 (1H,
brs, CH), 4.78 (1H, brs, CH); 13C NMR (100 MHz, DMSO-d6)
170.3, 165.6, 157.7, 148.8, 144.4, 129.7, 119.5, 97.2, 77.5; 13C
NMR (100 MHz, DMF-d7) 170.2, 165.7, 158.4, 148.6, 144.2,
129.4, 119.2, 97.4, 78.0; MS (ESI-MS, DMF and ACN, HCTul-
tra) m/z (Calcd 760.2; exp. 761.3, M + H+, 100%), (HRMS,
APCI-TOF, DMSO) m/z (Calcd 761.2314; meas. 761.2292,
M + H+).
(3S,4S,16S,17S)-Tetra-carbohydrazide cyclophane (10)
Prepared from (4S,5S)-1,3-dioxolane-4,5-dicarbohydrazide (4)
and isophthaldehyde as a white solid precipitate (99%); mp >
323 °C (decomp.); IR νmax/cm−1 3223 (NH), 1680 (CvO,
CvN); 1H NMR (400 MHz, DMSO-d6) δH 11.78 (4H, brs,
NH), 8.40 (1H, brs, CHvN), 8.07–7.96 (2H, m, CHvN),
7.88–7.14 (9H, m, CHvN and ArH), 5.46–5.40 (2H, m, CH),
5.23–5.08 (4H, m, CH2), 4.86–4.79 (1H, brs, CH), 4.52 (1H,
brs, CH); 13C NMR (100 MHz, DMSO-d6) δC 170.4, 165.8,
148.9, 144.5, 134.4, 129.7, 97.3, 77.5; MS (ESI-MS, DMF and
ACN, HCTultra) m/z (Calcd 576.2; exp. 599.1, M + Na+, 100%),
(HRMS, APCI-TOF, DMSO) m/z (Calcd 599.1609; meas.
599.1599, M + Na+).
(3R,4R,22R,23R)-Tetra-carbohydrazide cyclophane (14)
Prepared from (4R,5R)-1,3-dioxolane-4,5-dicarbohydrazide (2)
and 4,4′-diformyltriphenylamine as a yellow solid precipitate
(99%); mp > 224 °C (decomp.); IR νmax/cm−1 3214 (NH), 1681
1
(CvO, CvN); H NMR (400 MHz, DMF-d7) δH 11.38 (2H,
brs, NH), 11.22 (2H, brs, NH), 8.20 (1H, brs, CHvN), 7.92
(1H, brs, CHvN), 7.80 (1H, brs, CHvN), 7.74 (1H, brs,
CHvN), 7.49–7.22 (6H, m, ArH), 7.22–6.98 (6H, m, ArH),
6.91–6.77 (6H, m, ArH), 6.77–6.49 (8H, m, ArH); 5.32 (2H,
brs, CH), 5.06–4.94 (4H, m, CH2), 4.62 (1H, brs, CH), 4.46
(1H, brs, CH); 13C NMR (100 MHz, DMSO-d6) 170.3, 165.4,
148.3, 146.3, 144.4, 130.4, 129.1, 126.0, 125.2, 123.5, 97.1,
77.5; MS (ESI-MS, DMF and ACN, HCTultra) m/z (Calcd
910.3; exp. 911.5, M + H+, 100%), (HRMS, APCI-TOF,
DMSO) m/z (Calcd 933.3079 ; meas. 933.3048, M + Na+).
(3S,4S,17S,18S)-Tetra-carbohydrazide cyclophane (11)
Prepared from (4S,5S)-1,3-dioxolane-4,5-dicarbohydrazide (4)
and terephthaldehyde as a pale yellow solid precipitate (99%);
mp > 346 °C (decomp.); IR νmax/cm−1 3206 (NH), 1671 (CvO,
CvN); 1H NMR (400 MHz, DMSO-d6) δH 11.77 (2H, brs,
NH), 11.62 (2H, brs, NH), 8.36 (1H, brs, CHvN), 7.92–7.87
(2H, m, CHvN), 7.80–7.18 (9H, m, CHvN and ArH),
5.37–5.00 (6H, m, CH and CH2), 4.76 (1H, brs, CH), 4.22 (1H,
brs, CH); 13C NMR (100 MHz, DMSO-d6) δC 170.7, 165.4,
146.1, 144.2, 135.3, 128.0, 97.0, 77.8; MS (ESI-MS, DMF and
ACN, HCTultra) m/z (Calcd 576.2; exp. 577.1, M + H+, 100%),
(HRMS, APCI-TOF, DMSO) m/z (Calcd 577.1429; meas.
577.1450, M + H+).
(3S,4S,22S,23S)-Tetra-carbohydrazide cyclophane (15)
Prepared from (4S,5S)-1,3-dioxolane-4,5-dicarbohydrazide (4)
and 4-(4-formylphenoxy)benzaldehyde as a white solid precipi-
tate (98%); mp > 305 °C (decomp.); IR νmax/cm−1 3219 (NH),
1
1681 (CvO, CvN); H NMR (400 MHz, DMSO-d6) δH 11.65
(4H, brs, NH), 8.35 (1H, brs, CHvN), 8.07 (1H, brs, CHvN),
7.93 (1H, brs, CHvN), 7.71–7.52 (8H, m, CHvN and ArH),
7.43 (1H, brs, ArH) 7.10–6.66 (8H, m, ArH), 5.42 (2H, brs,
CH), 5.22–5.05 (4H, brs, CH2), 4.75 (1H, brs, CH), 4.54 (1H,
brs, CH); 13C NMR (100 MHz, DMSO-d6) 170.3, 165.6, 157.7,
(3S,4S,21S,22S)-Tetra-carbohydrazide cyclophane (12)
Prepared from (4S,5S)-1,3-dioxolane-4,5-dicarbohydrazide (4)
and 4,4′-diformylbiphenyl as a yellow solid precipitate (97%);
mp > 340 °C (decomp.); IR νmax/cm−1 3210 (NH), 1673 (CvO,
Org. Biomol. Chem.
This journal is © The Royal Society of Chemistry 2012